Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use Cronus Pharma LLC, a veterinary pharmaceutical company focused on developing high-quality, cost-effective animal health products, today announced the U.S. launch of Robenacoxib Injection, the only FDA-approved bioequivalent to ONSIOR® (robenacoxib)…
Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Durvalumab Plus Chemotherapy in First-Line Advanced Biliary Tract Cancer in Single-Region Trial Conducted by Akeso in China Summit Therapeutics Inc. noted that its partner Akeso Inc. announced positive topline…
Maxis AI Introduces the First Verticalized Context Layer for Life Sciences, a Governed Execution Fabric That Makes Enterprise AI Reliable, Cost-Efficient, and Regulatory Compliant Maxis AI introduced MaxisAI Holarchy, its Verticalized Context Layer, a governed institutional memory that gives life sciences…
Carna Health and Level Up Sign a Memorandum of Understanding to Advance Preventive Healthcare in Kazakhstan Carna Health, an AI-enabled digital health company revolutionizing Cardio-Kidney-Metabolic (CKM) care, announced the signing of a Memorandum of Understanding (MOU) with Level Up to…
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Continued Collaboration with the University of Georgia Lōkahi Therapeutics™, a subsidiary of Glucotrack, Inc. announced the continued participation of the University of Georgia’s Student Industry Fellows Program in the ai²…
American Chemical Society Names Syngenta’s Camilla Corsi the 2026 Winner of Prestigious International Award for Research in Agrochemicals Camilla Corsi, Head of Crop Protection Research & Development at Syngenta, is the winner of the prestigious 2026 American Chemical Society (ACS)…
European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across PD-L1 Status Gilead Sciences, Inc. announced that the European Commission (EC) has granted marketing authorization for Trodelvy® (sacituzumab govitecan-hziy) in combination with Keytruda® (pembrolizumab) for the treatment of adult…
BASF and NEO Corporate Launch Strategic Partnership to Advance Innovation in Personal Care Solutions BASF and NEO Corporate Public Company Limited announced a strategic partnership to advance next generation Personal Care solutions through the joint development of innovative formulations, ingredient technologies and…
Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study Revelation Biosciences, Inc., a clinical-stage life sciences company focused on developing innovative therapies for acute and chronic diseases, has announced the selection of Avance Clinical as the contract…
NTx Bio Powers Baylor College of Medicine’s Manufacturing of a Personalized Cancer Vaccine in Diakonos Oncology’s Phase 1 Refractory Melanoma Trial NTx Bio, a leader in next-generation biomanufacturing technologies, announced that its NTxscribe® CORE platform is being used by researchers at Baylor College…
UNC Health Launches UNC Health Ventures, Marking Next Phase of Strategic Investment Platform UNC Health today announced the rebranding of Rex Health Ventures and the launch of UNC Health Ventures, its corporate venture capital and strategic investment platform. The platform builds…
GenBio AI Builds First World Model of the Human Cell GenBio AI is an AI for Science company co-founded by Nobel Laureate David Baker, leading AI scientist Eric Xing, and other prominent life science and artificial intelligence researchers from Stanford,…